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ABSTRACT
Post-exercise hypotension (PEH) is believed to play a major role in the
antihypertensive health benefits of exercise. While it has been shown that resistance
exercise is effective at eliciting PEH, commonly consumed sports supplements may
attenuate or completely eliminate that response. Caffeine, a popular stimulant, is often
consumed prior to exercise. Therefore, the purpose of this study was to investigate the
effects of pre-workout caffeine supplementation on the post-exercise hypotensive
response in adults with above normal blood pressure. Participants (n = 5) were
recreationally resistance trained men and women who consumed placebo or caffeine (3
mg/kg bodyweight) 45-minutes prior to exercise. The resistance exercise session
consisted of four sets of 10 reps for bench press, cable row, leg press, and shoulder press
at 70-75% one repetition maximum. Blood pressure and heart rate were measured preexercise, during exercise, and 90 minutes post-exercise. Caffeine supplementation
resulted in significantly greater SBP at 30, 50, 60, 70, and 80 minutes post-exercise
compared to placebo condition. These findings indicate that pre-workout caffeine
supplementation eliminates the post-exercise SBP hypotensive response that was
observed in the placebo condition and should be avoided if the antihypertensive effects of
resistance training are to be fully achieved
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INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death in the United States
and accounts for more than 600,000 deaths each year (64). There are multiple risk
factors, modifiable and non-modifiable alike, associated with the development of CVD.
These risk factors include, but are not limited to, physical inactivity, diet, cigarette
smoking, obesity, dyslipidemia, and hypertension (64). Hypertension (HTN) is
considered the most important and strongest contributor to CVD and it currently affects
nearly half of U.S adult population (65). As a modifiable risk factor, hypertension can be
improved through the modification of long-term lifestyle habits. Diet and exercise are at
the forefront of lifestyle modifications as they have proven effective in preventing and
treating HTN alone or in combination (66).
The acute decrease in blood pressure (BP) following exercise is known as postexercise hypotension (PEH) and is believed to play a major role in the antihypertensive
health benefits of exercise (23). Traditionally, aerobic exercise has been favored over
resistance exercise in prescriptions and recommendation guidelines for the prevention
and management of HTN (46). However, more recently resistance exercise has been
recognized to be just as effective as aerobic exercise at acutely lowering BP (12, 36, 46).
Resistance exercise has been shown to acutely lower BP by 3 mmHg, however greater
decreases are observed in those with hypertension (6 mmHg) and even larger in nonwhite hypertensives (10 - 14 mmHg) (36). As resistance training has only recently been
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observed as an effective method in BP management, research is in its infancy. As such,
the ideal characteristics of the resistance exercise intervention remain largely unknown.
While it has been shown that resistance exercise can elicit PEH, certain sports
supplements may attenuate or eliminate the BP related health benefits when taken in
conjunction with exercise. The use of sports supplements has become widely popular and
the industry continues to grow with at least 55,000 different products available in the
United States that account for nearly $30 billion in spending (14, 60). A place of
significant growth in the industry has been multi-ingredient pre-workout supplements
(MIPS) and energy drinks (29). The primary ingredient in such products is caffeine due
to its effect on the central nervous system and its stimulant properties (29). Additionally,
caffeine is the most widely consumed substance in the world and nearly 90% of
Americans consume some form each day whether through coffee, energy drinks, MIPS or
otherwise (53). In particular, caffeine and its associated supplements have gained in
popularity for fitness enthusiasts and recreationally active individuals who do not
necessarily require the ergogenic benefit of caffeine to perform (53). Furthermore, it has
been postulated that caffeine may attenuate or eliminate the BP related benefits of
exercise attributed to PEH. Despite the widespread consumption of caffeine and its
recognition as a substance that affects blood pressure (18, 53), very few studies have
investigated its effect on PEH. The inherent lack of research leaves a critical question
unanswered: do these popular, unnecessary supplements do more harm than good?
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Of the existing literature, most of the research focuses on the interaction of
caffeine and aerobic exercise. To our knowledge, only two studies have investigated the
effects of caffeine on the PEH response following resistance exercise, and the findings
have been conflicting (3, 58). For example, Souza et al., (58) concluded that in
normotensive adults, 4 mg/kg of caffeine 45 minutes prior to resistance exercise at 70%
1RM for 3 sets of 10 resulted in a greater 9-hour ambulatory BP measurement across all
time points compared to placebo (58). However, PEH was still observed with caffeine
consumption (58). In contrast, Astorino et al (3) concluded that caffeine intake (6 mg/kg)
prior to intense resistance exercise (70-80% 1RM) for 4 sets of maximum reps
completely eliminated the PEH response during 75 minutes of seated rest in
normotensive and prehypertensive men. The opposing findings of the studies by Astorino
et al (3) and Souza et al (58) may be attributed to the variation in methodology regarding
dosage, exercise volume, and time course of PEH observation. Given the novelty of the
research, variability in methods, and conflicted outcomes, more research is necessary to
determine if caffeine consumption negates the blood pressure related health benefits of
exercise. As the sports supplement industry continues to grow and prevalence of HTN
steadily rises, understanding the effects of one on the other has become increasingly
important. Therefore, the purpose of this study is to investigate the effect of pre-exercise
caffeine consumption on the post-exercise hypotensive response following resistance
training in recreationally trained men and women with above normal blood pressure.
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REVIEW OF LITERATURE

Acute Blood Pressure Response to Exercise
During dynamic aerobic exercise, systolic blood pressure (SBP) increases linearly
with exercise intensity, while a maintenance or slight decrease of diastolic blood pressure
(DBP) is observed (23). A “normal” blood pressure (BP) response during exercise, as
defined by the American College of Sports Medicine, is an increase in SBP by 10±2
mmHg per metabolic equivalent (MET), although this is still a matter of debate due to
individual variances and minimal empirical evidence (16). The change in exercising BP
is determined by cardiac output, total peripheral resistance, and sympathetic activity (19).
The rise in SBP is largely due to the increase of cardiac output (CO) in order to
meet the metabolic needs of the active muscle (23). Increases in heart rate and
contractility due to withdrawal of parasympathetic tone and the subsequent increase in
sympathetic activity contributes to the observed increase in cardiac output. The metabolic
needs of the muscle are further assisted by the redistribution of blood flow through
vasoconstriction of the gastrointestinal and renal vessels and a concurrent blunting of
skeletal muscle vasoconstriction due to release of vasodilators, such as adenosine and
nitric oxide (NO) in the active muscle (23). The reduction in systemic vascular resistance
due to the vasodilation of skeletal muscle arterioles and concurrent increases in heart rate
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observed at increasing intensities of exercise, leave DBP mostly unchanged during acute
exercise (23).
The blood pressure response during exercise differs by individual, as well as by
exercise mode and intensity. The previously described response (SBP increasing linearly
with workload and DBP decreasing or remaining the same through a large increase in CO
and a decrease in vascular resistance) typically applies to acute aerobic exercise.
However, both SBP and DBP typically react more significantly during resistance training
due to a more modest increase of CO, an increase or no change in vascular resistance, and
mechanical compression/constriction of vessels (23). The BP response during resistance
training is cyclical and dependent on the specific phase of the lift: increases during
concentric contraction, decreases at completion of the movement, increases again through
eccentric contraction in the lowering phase. For both aerobic and resistance training,
blood pressure rapidly returns to baseline at termination of exercise, often returning to
levels below the pre-exercise baseline. This transient reduction in blood pressure is
known as post-exercise hypotension (PEH) and is thought to be one of the acute benefits
to exercise (23).
Post-Exercise Hypotension
The phenomenon of a transient decrease in blood pressure following exercise was
first observed in 1898 by L Hill after he monitored blood pressure for 90 minutes post
400-yard dash (27). This phenomenon is now termed post-exercise hypotension. Since
the original observation, PEH has been demonstrated in both normotensive and
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hypertensive men and women with a variety of exercise prescriptions (27). This review
will cover the various exercise prescriptions that have been utilized to elicit PEH, as well
as discuss the internal physiological mechanisms and other external factors that impact
this response. Several factors have been identified to impact the magnitude and duration
of the PEH response, including the exercise mode, intensity, and inherent BP of the
subject.
Aerobic Exercise and PEH
The effects of aerobic/endurance training on PEH has been extensively researched
(15, 19, 24, 28). It is generally accepted that PEH occurs in a dose-response fashion to the
exercise intensity and duration, however some have observed no difference in the
magnitude of PEH based on intensity or duration (Ham06).
Eicher and colleagues (19) determined that varying exercise intensities on a cycle
ergometer elicited significantly different PEH responses. The subjects, 45
prehypertensive males aged 18-55, completed a control trial of 45-minute seated rest and
three separate exercise trials at low (40% VO2peak) and moderate (60% VO2peak) intensity
for 40 minutes and vigorous (100% VO2peak) intensity until volitional fatigue. Each trial
was followed by 45 minutes of seated recovery with BP automatically measured every 3
minutes. Participants were then fit with an ambulatory blood pressure cuff (ABPM) to
assess the PEH response for 9 waking hours. As the intensity increased, the greater the
PEH response (Vigorous: -11.7/-4.9 mmHg; Moderate: -5.4/-2.0 mmHg; Low: -2.8/-1.5
mmHg). As a result, PEH occurred in a dose-response fashion with each 10% increase in
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intensity, SBP and DBP fell by 1.5 mmHg and 0.6 mmHg, respectively (19). Similarly, a
study conducted on 23 normotensive males and females found a more significant PEH
response with more intense exercise (24). Subjects completed three randomly assigned
45-minute sessions on a cycle ergometer at low, moderate, and vigorous intensity (30%,
50%, & 70% VO2peak). As intensity increased, the greater and longer the PEH response
(24). Conversely, Cornelissen et al (15) determined an equally significant PEH response
following 50 minutes of aerobic exercise at low (33% HHR) and vigorous (66% HHR)
intensities. The study population included trained and untrained normotensive individuals
(15). A study conducted on hypertensive older males also demonstrated a non-significant
difference in PEH at low (40% VO2MAX) to moderate (60% VO2MAX) intensity (47).
Despite the earlier findings that suggest intensity has no impact on PEH, recent research
continues to support the dose-response fashion of aerobic associated PEH.
Resistance Exercise and PEH
Resistance training is often supplemented to aerobic training in HTN prevention
and treatment. However, the effect of resistance training on PEH is new and not widely
studied. Similarly, to aerobic training, there is believed to be a dose-dependent response
of PEH following resistance training, but again no consensus has been reached due to 1)
general lack of studies and 2) conflicting evidence from existing studies. Rezk et al (54)
sought to determine whether lower (40% 1RM) or higher intensities 80% 1RM) of
resistance training would induce a greater PEH response. Participants were normotensive
adults who completed 6 upper and lower body exercises for 3 sets of 20 reps. Both
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intensities resulted in PEH of the same duration, but high intensity elicited a greater
magnitude (54). Similarly, Duncan and colleagues (17) investigated the extent of PEH in
16 trained normotensive and prehypertensive men. Participants randomly completed both
low (40% 1RM) and high (80% 1RM) intensity sessions with 3 sets of back squat, bench
press, and deadlift. The study found that recovery blood pressure was significantly lower
following the high intensity compared to low intensity (17). On the contrary, a study
evaluated the effect of low intensity (40% 1RM) resistance training on PEH in medicated
hypertensive women (41). The exercise sessions included 3 sets of 20 reps for bench
press, leg curl, biceps curl, and back squat. The low intensity exercise significantly
decreased blood pressure, which persisted for 10 hours post (41). Lastly, a recent 2016
meta-analysis evaluated 30 studies on the effect of resistance training on PEH and
concluded that both low and high intensities elicit similar reductions in blood pressure
following training (12).
External Factors in PEH
In addition to the exercise prescription parameters, there are a variety of external
factors proposed to influence PEH; gender, diurnal variation, recovery posture, inherent
blood pressure, and caffeine (37).
Inherent Blood Pressure
Inherent blood pressure is perhaps the most important and well-established of
these external factors. Typically, prehypertensive and hypertensive individuals
experience a more dramatic and prolonged PEH response compared to normotensives
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(11, 50). This response follows the “baseline law” which states that individuals with a
greater initial BP will experience the greatest drop in BP following exercise (46).
Accordingly, unmedicated hypertensive subjects would be expected to experience a
greater magnitude of PEH compared to medicated hypertensives whose baseline BP is
closer to “normal” as well as prehypertensive and normotensive individuals.
Gender
It has been hypothesized that men and women may experience PEH differently
based on the varying gender specific physiological responses and adaptations to exercise
as well as the presence or absence of a menstrual cycle (40, 51). However, these
hypotheses have not been supported as many studies show no significant difference in
PEH between men and women of similar resting blood pressure (49, 55) and no
significant difference in the pattern and overall occurrence of PEH during various phases
of the menstrual cycle (20, 35). To put it simply, the menstrual cycle can be broken into
two overarching phases: The follicular phase and the luteal phase, both of which are
commonly divided into early, mid, and late phase categories (52). Estrogen levels are
highest during late follicular (LF) and mid luteal (ML) phases, while levels are lowest
during the early follicular (EF) phase (52). The cardioprotective effect of estrogen has
recently led to question if and how fluctuating levels of estrogen during the menstrual
cycle can affect the PEH response. Presumably, the first study to investigate the
menstrual cycle phase on PEH, Esformes et al (20) concluded that the PEH response is
similar in pattern, but different in magnitude. The subjects were eight eumenorrheic
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young women who completed 3 separate exercise trials at 80% lactate threshold for 30
minutes on a cycle ergometer during the EF, LF, and ML phases. The post-exercise
response was measured for 45-min in the supine position. In addition to the similar
overall PEH response, it was also observed that the magnitude of DBP and MAP were
significantly lower during recovery compared to rest in solely the EF phase, which led to
the conclusion that the PEH response was buffered in the LF and ML phases when
estrogen levels are naturally higher (20). The major limitation of the study was the
absence of blood or urine tests to ensure participants were in varying phases of the
menstrual cycle based on estrogen levels as up to 40% of women may have cycles that
are considered short, anovulatory, and/or inadequate (52). This lack of determination may
have resulted in some subjects not experiencing the normal and expected variations in
estrogen in each phase, which could have led to skewed results. Arguably a more robust
study, Lynn et al. (35), determined that PEH is largely unaffected by the menstrual cycle
and estrogen. Subjects of this study were apparently healthy males and females (M = 14,
F = 14). All females were eumenorrheic and not on any oral contraceptive for at least 6
months. The exercise trial(s) consisted of 60 minutes cycling at 60% VO2PEAK. Males
completed one trial while females completed three separate trials in the EF, LF, and ML
phase determined through blood samples. Post-exercise blood pressure was measured for
90 minutes in the supine position. There was no statistically significant difference in
pattern or magnitude of PEH between men and women, as well as no significant
difference between phases (35). Contrary to Esformes et al (20), a lower baseline BP was
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observed in the ML phase compared to the EF and LF phases, however the baseline
differences did not directly affect the overall PEH response (20, 35). Lastly, a handful of
studies have shown a difference in PEH mechanism of action based on gender; a decrease
in CO is responsible for PEH in men, while a reduction in SVR is responsible in women
(40, 51). Still, despite the mechanical differences, research has yet to document a
significant difference in PEH between genders. From these studies, it can be concluded
that gender does not affect PEH and the inclusion of women is not only plausible, but
necessary. Due to the novelty of research on the direct effect of menstrual cycle on PEH,
it would be advantageous to test all female participants in the same phase or have female
subjects complete two separate trials: a phase when estrogen is low (EF) and a phase
when estrogen is high (LF or ML).
Diurnal Variation
Diurnal variation, the physiological changes that occur specific to time of day, are
an important external factor in regard to the magnitude of PEH (43). Some studies agree
that PEH is more dramatic in the afternoon compared to the morning presumably due to
the morning-associated decrease in vasodilatory substances and increase in sympathetic
tone (4, 31). However, a recent study found that when circadian variation is controlled
for, PEH is not significantly different in the morning vs. evening (9). This process of
controlling for circadian variation is extensive and time-consuming, so it may not be
plausible for many studies. Research on diurnal variation and PEH is limited and
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conflicted, therefore it may be necessary to conduct trials at the same time of day and
possibly limit trials to the afternoon to eliminate the effect of diurnal variation.
Recovery Posture
Recovery posture, seated vs supine, has been postulated to play a role in PEH.
Seated recovery exacerbates venous pooling by positioning vasodilated vessels below the
heart (6). As a result, venous return is diminished as well as preload, stroke volume, and
cardiac output. Consequently, a fall in blood pressure occurs. The supine recovery
position equalizes the effect of gravity on the body and venous blood and pressure is
distributed more evenly, leading to the thought that supine recovery could potentially
reduce the effect of PEH (44). In terms of practicality, both recovery positions can be
correct based on the population in question and the time of day exercise would be
performed. For example, an exercise trial conducted at night would necessitate the supine
recovery position as the population who would exercise at night presumably lies down to
sleep after exercise. On the other hand, for morning or afternoon exercise the seated or
standing position may be more practical as the population would typically be in either
one of these positions during waking hours. In conclusion, it is necessary to report which
recovery position is utilized as well as to choose a recovery position based on the
practical application of results. While the external factors that elicit physiological
changes and the subsequent PEH responses are highly variable, the internal physiological
factors have been elucidated.
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Internal Physiological Mechanisms of PEH
Cardiac output and total peripheral resistance are major determinants of arterial
BP; therefore, any change must be attributed to either an increase or decrease in one or
both variables, which can occur due to central and/or vascular mechanisms (26). It has
been proposed that the transition from exercise to rest causes an imbalance in these two
determinants as cardiac output decreases rapidly, although not back to resting levels,
while the reduction in SVR is more sustained resulting in lower arterial pressures.
Recent research has focused on the sustained vasodilation of active muscles as the
primary internal mechanism of PEH due to changes in the baroreflex that manifests as a
reduction in SVR. Essentially, at the onset of exercise, the baroreflex arc begins to
operate at a higher level thereby increasing sympathetic tone. The termination of exercise
“resets” the baroreflex, decreasing sympathetic tone further than baseline levels.
Alongside the decreased sympathetic nerve activity, an increase in vasodilatory
substances occurs (26). Of particular importance, the increased release of nitric oxide and
adenosine as a response to acute exercise is believed to play an important role in PEH.
These factors work together to cause a reduction in SVR in the active muscles as well as
non-exercising tissues, suggesting that PEH is part of a systemic response (26). While the
internal physiological factors have been elucidated the external factors that elicit these
changes and the subsequent PEH response are more variable.
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Overview of Caffeine
Caffeine is the most widely consumed substance in the world with nearly 90% of
the American population consuming some form of caffeine each day (53). It is naturally
found in chocolate, coffee, and tea, and is an added ingredient in soda, energy drinks, and
sports supplements (61). The greatest contribution of caffeine intake, 98%, is attributed to
caffeinated beverages. Levels of ≤ 400 mg/day, equivalent to four cups of coffee, has
been established as safe in the general population. Certain sub-groups, such as
adolescents, pregnant or breastfeeding women, and hypertensive adults (≤ 200 mg/day)
have more stringent recommendations for safe caffeine intake without adverse effects
(59). The average adult, 18-55 years of age, consumes 200 mg/day (61). Because of its
widespread consumption, the physiological effects and pharmacokinetics of caffeine has
been extensively researched.
Intake and Metabolism
Alsabri et al (1) offer a thorough review on caffeine intake and metabolism.
Caffeine can be consumed in a variety of forms, such as those previously mentioned, as
well as in the form of chewing gums, tablets/capsules, and powder as caffeine anhydrous.
Caffeine is rapidly and readily absorbed following oral consumption with 99% of the
substance absorbed in 45 minutes. Overall absorption of caffeine does not differ by
forms, however initial absorption rates do vary. Gum, compared to tablets/capsules, is
absorbed more rapidly with absorption beginning in the mouth through buccal mucosa.
Dependent on the form of administration, peak blood levels of caffeine are reached 30-60

14

minutes after ingestion. As an amphiphilic molecule, caffeine (C8H10N4O2) is soluble in
both water and lipids. Because of this quality, caffeine can cross all biological
membranes, including the blood-brain barrier and placenta. Only 10-30% of caffeine is
found bound to plasma protein, which demonstrates caffeine's ability to efficiently and
freely distribute across all tissues. The average half-life of caffeine is 3-5 hours.
However, half-lives as little as 1.5 hours and as much as 9 hours have been recorded in
research. Caffeine is metabolized in the liver by the CYP1A2 pathway where it is broken
down into three major metabolites: Paraxanthine (84%), Theobromine (12%), and
Theophylline (4%). Metabolism and elimination are affected by individual variations,
such as age, obesity, pregnancy, and genetic variations in the enzyme responsible for
caffeine metabolism. Physiological and environmental factors such as smoking, use of
oral contraceptives, grapefruit consumption, and altitude also impact rate of metabolism
and elimination, subsequently influencing half-life. Elimination of caffeine is by first
order kinetics and only a small percentage is excreted in urine due to the reabsorption of
caffeine by the renal tubules following glomerular filtration (1).
Caffeine as an Ergogenic Aid
Keisler and Armsey (33) provide an extensive review of caffeine as an ergogenic
aid. The use of caffeine to enhance exercise performance is widespread and supported by
evidence-based results. It has been shown to increase alertness, improve cognitive
performance, increase time to fatigue, and decrease perception of work, all of which are
beneficial for exercise performance. As a result of caffeine’s ability to cross all biological
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membranes and affect all tissues, a specific mechanism of action regarding caffeine and
exercise performance has yet to be established. Over the years there have been many
proposed mechanisms to explain the ergogenic effect of caffeine. Perhaps the earliest
proposed mechanism comes from Powers and colleagues who observed increased free
fatty acid oxidation during aerobic exercise. It was thought that this led to a delay in
depletion of muscle glycogen stores, a decrease in lactic acid production, and
consequently the ability to exercise longer. However, current research does not support
these findings, which suggest other potential mechanisms of action to explain the
ergogenic effect of caffeine (33).
Similarly, it has been proposed that through the inhibition of the enzyme
phosphodiesterase, muscle glycogen is spared by an increase in fat oxidation (33). More
specifically, the enzyme phosphodiesterase is responsible for the breakdown of cyclic
adenosine monophosphate (cAMP). The inhibition of phosphodiesterase leads to an
accumulation of cAMP which will activate the hormone lipase. Lipase stimulates
lipolysis and as a result, free-fatty acids are released and transported to active tissue for
energy. The dosage required to elicit a physiological response in humans would be toxic
and therefore this mechanism is also unlikely to describe the ergogenic effect of caffeine
(33).
Research has indicated that caffeine consumption activates ryanodine receptors
within skeletal muscle, which leads to increased calcium release from the sarcoplasmic
reticulum (33). It is hypothesized that activation of ryanodine receptors also leads to
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increased sensitivity of the muscle fiber to calcium and decreased activity of the
sarcoplasmic reticulum calcium pump. The effect is mediated by stored levels of calcium
and dosage of caffeine. Research has shown supraphysiological levels of caffeine would
be required to generate an ergogenic effect (33).
Perhaps the most popular and plausible mechanism of action is the ability of
caffeine to act as a non-specific antagonist on adenosine receptors in the brain and
peripheral tissues (33). Although some research suggests a reduction in muscle pain and
perceived force as a result of adenosine receptor blockage within skeletal muscle, much is
still unclear regarding adenosine and skeletal muscle. Therefore, the key mechanism
regarding caffeine and exercise performance is believed to occur within the central
nervous system. Caffeine and its main metabolite, paraxanthine, cause a cascade of
events opposite to the function of adenosine, which is responsible for the feeling of
tiredness/sleepiness. As a result, caffeine has been shown to delay or even prevent
feelings of fatigue. The release of the neurotransmitter’s dopamine, serotonin,
acetylcholine, and epinephrine are controlled and inhibited by adenosine. Caffeine
consumption prevents the action of adenosine and encourages the release of
neurotransmitters, which is associated with the ergogenic effects seen with caffeine (33).
Vascular Effects of Caffeine
Echeverri et al (18) provide an extensive review on the vascular effects of
caffeine. Although caffeine is one of the most widely consumed substances around the
world, its effect on the cardiovascular system is not completely understood. The main
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cardiovascular component affected is believed to be blood pressure. Acutely, a 200-250
mg dose of caffeine raises SBP and DBP in normotensives by 3-14 mmHg and 4-13
mmHg respectively. The rise in blood pressure with caffeine occurs in line with plasma
concentration; BP begins to increase within 30 minutes following consumption and
reaches maximal levels at 60-120 minutes. The primary vasopressor mechanisms of
caffeine include its ability to antagonize adenosine receptors, and to a lesser extent, its
direct and indirect action on the endothelium and vascular smooth muscle cells (VSMC).
As previously discussed, caffeine acts as an adenosine A1 and A2 receptor blocker
and thereby restricts the vasodilatory function of adenosine. As a result, plasma
concentration of adenosine accumulates and an increase in sympathetic tone, circulating
catecholamines (specifically norepinephrine), and peripheral vascular resistance is
observed. The cumulative effect is indirect vasoconstriction that manifests as an increase
in blood pressure (18).
As one of the most extensive tissues in the human body, the endothelium is
responsible for many aspects of vascular biology. The most important function here is the
maintenance of VSMC tone through an intricate balance in the release of vasoconstrictors
and vasodilators, particularly nitric oxide. Caffeine activates endothelial ryanodine
receptors which stimulates the release of calcium from the endoplasmic reticulum.
Cytoplasmic calcium binds to the protein calmodulin which forms a complex that
enhances the activation of nitric oxide synthase. Therefore, caffeine directly results in the
release of nitric oxide from the endothelium that rapidly diffuses into VSMC. The end
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result of this process is vasodilation and improved endothelial cell function at rest.
However, caffeine and exercise results in decreased endothelial cell function, presumably
due to the duality of caffeine’s role in endogenous nitric oxide production based on rest
or exercise. The vasodilation effect of caffeine may be antagonized by the simultaneous
inhibition of adenosine receptors. The effect on adenosine is believed to be the
predominating cardiovascular mechanism, due to lack of in vivo research and the large
doses proposed to be necessary to elicit the calcium response of the endothelium and
VSMC. Lastly, the effect of caffeine on post-exercise hypotension is largely unknown
(18).
Influence of Habituation
In regard to chronic intake of caffeine, research has shown an inconclusive
contribution to hypertension and other cardiovascular disease, which is believed to be as
a result of long-term intake increasing tolerance to the pressor effect (42). The influence
of habituation on the ergogenic and cardiovascular effect of caffeine is not completely
understood. Previously, it was hypothesized that caffeine-naive individuals experience
greater ergogenic effects than habitual caffeine users, however recent research has
reported conflicting results. Some report no difference while others report a blunting of
erogenicity (25, 48). The key mechanism believed to be responsible for the reduction in
ergogenic effect experienced with habitual caffeine intake is the up-regulation of
adenosine receptors and increased speed of the CYPA12 enzyme (34). The dosage and
time required to elicit habituation is not definitive, but most research has established
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>300 mg/day for at least three days (21, 48). The blunted ergogenic response could
potentially be offset by consuming doses greater than usual prior to exercise or through
short-term withdrawal leading up to an event (34). Due to conflicting results and an
unclear understanding on the effect of caffeine habituation, it may be advantageous to
avoid using caffeine-naive individuals in research that is aimed at determination of and/or
effect on physiological responses.
Caffeine and Post-Exercise Hypotension
Despite the widespread consumption of caffeine and recognition as a stimulant
that acutely affects blood pressure, very few studies have investigated the effect of
caffeine consumption on post-exercise hypotension. Of the existing literature, outcomes
are conflicting.
To determine the effect of caffeine on recovery hemodynamics, Souza et al (58)
recruited 15 healthy adults (12 Males, 3 Females) with recreational resistance training
experience to participate in the double-blind, placebo controlled, crossover study. All
participants were considered light caffeine habituated, which was defined as an average
daily intake of less than 250 mg. Prior to the study, participants were instructed to abstain
from caffeinated beverages, vigorous exercise, and alcohol for at least 72 hours prior to
testing. All participants had 1RM tests administered for the following lifts: Lat pulldown,
knee flexion, chest press, knee extension, bicep curls, leg press at 45 degrees, and triceps
curls. At least 72 hours later, participants completed either the caffeine or placebo trial
between the morning hours of 8:00 and 9:00 am. Resting BP values were taken after 10
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minutes of seated rest using an automated blood pressure device. Once baseline values
were recorded, participants randomly received an identical capsule of either placebo or
caffeine. All participants received both capsules and completed the trial on nonconsecutive days. The caffeine capsules contained 4 mg/kg of caffeine. Participants
would then wait 45 minutes before completing the exercise session. At the end of the 45
minutes, blood pressure and other hemodynamic values (cardiac output, stroke volume,
and peripheral vascular resistance) were measured. The exercise session consisted of a 5minute warm-up and then 3 sets of 10 reps at 70% 1RM with 90 seconds of rest between
each set. The exercises were the same as listed above for 1RM assessment. Blood
pressure and hemodynamic variables were assessed again 15 minutes post-exercise as
well as blood pressure measured every 30 minutes for 9-hours post with an ambulatory
blood pressure monitoring device. Most significantly, caffeine ingestion resulted in
greater blood pressure across all time points when compared to placebo, however PEH
was still present (58).
Two years later, the same research team sought to determine the influence of
varying doses of coffee on PEH in hypertensive adults (57). Subjects were both genders
(9 females, 3 males) between the ages of 40-55 who participated in regular jogging for at
least three months, but were overweight with controlled hypertension. All subjects were
instructed to abstain from caffeinated beverages for at least 48 hours prior to the study.
Baseline values were measured after 10 minutes of seated rest with a standard mercury
sphygmomanometer. The intervention included four separate exercise sessions on a cycle
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ergometer for 40 minutes at 60-80% max heart rate. For 120 minutes post-exercise, blood
pressure was assessed in 10-minute intervals in the seated position. Particularly unique to
this study, participants ingested caffeine up to 30 minutes post-exercise depending on the
dosage. Each participant randomly received all four caffeine interventions: CAF1: 150 ml
of coffee once at 10 minutes post for a total of 144 mg caffeine; CAF2: 150 ml of coffee
twice at 10 and 20 minutes post for a total of 288 mg caffeine; CAF3: 150 ml of coffee
thrice at 10, 20, and 30 minutes post for a total of 432 mg caffeine; DESC: 150 ml
decaffeinated coffee thrice at 10, 20, and 30 minutes post for a total of 108 mg caffeine.
Both forms of coffee were sourced from the same manufacturer and were prepared with
500 ml of boiling water and sweetened with sugar. Blood pressure was measured every
10 minutes for a total of 120 minutes using a standard mercury sphygmomanometer.
Post-exercise hypotension was observed at all time points in DESC as well as at 10, 20,
and 90 minutes in CAF1. Systolic BP was increased in CAF2 and CAF3 at all time points
and DBP was increased at each time point for all three caffeinated interventions.
However, statistical significance was only found at 10 minutes post-exercise in CAF2
and CAF3 when compared to CAF1. These results suggest that one dose of caffeine is
enough to blunt the systolic PEH response, while two and three doses completely
eliminate PEH and instead result in a post-exercise hypertensive response (57).
A 2006 study by Notarios and colleagues (45) investigated the effect of
intravenous caffeine on the post-exercise blood pressure response based on the
hypothesis that caffeine blocks the vasodilator action of adenosine. The subject
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population included 14 healthy, middle aged adults. In this double-blind, placebo
controlled, crossover study participants completed two separate testing days at least one
week apart. Participants were instructed to abstain from caffeinated food and beverages
for at least 72 hours and to consume their last meal at least 2 hours before the trial. Prior
to the exercise session, blood pressure was measured with a sphygmomanometer and then
an antecubital catheter was inserted into the right arm forearm. Over the time course of
20 minutes, 4 mg/kg of caffeine or placebo were intravenously infused. After infusion,
participants sat in the upright position for 10 minutes before exercise. The exercise
session was a graded cycle ergometer test that increased intensity by 17 Watts per minute
until volitional failure, which was determined by a respiratory exchange ratio greater than
1.1 or the inability to maintain pedaling speed. At termination, participants completed an
active recovery on the bike for two minutes. Post-exercise blood pressure was assessed
for 10 minutes post. The key result was that caffeine completely eliminated the PEH
response over the 10-minute recovery period (45)
Astorino et al (3) concluded that regardless of caffeine ingestion, intense
resistance training completely eliminated the PEH response. The present study was
conducted on 14 resistance trained normotensive and prehypertensive men. Prior to the
study, participants were educated on caffeinated foods and beverages and were instructed
to avoid consumption for at least 48 hours prior to the two testing days. Upon arrival at
the testing facility, baseline blood pressure was measured after 5 minutes of rest with an
automated blood pressure device. Shortly after, participants 1RM was measured for
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bench press, leg press at 45 degrees, bilateral row, and barbell shoulder press. One week
after baseline measurements, participants returned for testing at the same time of day.
Participants were randomly assigned to receive caffeine (6 mg/kg) or placebo, both of
which were provided in identical capsules. One hour after ingestion of caffeine or
placebo, participants began the resistance training protocol. In the one-hour time frame,
resting BP measurement was taken for 30 minutes every 10 minutes. As a warm-up,
participants walked to the fitness center and completed 8-10 reps of bench press. For the
actual exercise intervention, participants completed 4 sets of maximum repetitions at 70%
1RM on bench press and shoulder press and 80% of 1RM on leg press and bilateral row.
Following the exercise session, participants returned to the lab for 75 minutes of seated
recovery with BP measured every 25 minutes. Participants returned one week later for the
opposite treatment. The study found no change in DBP between placebo or caffeine, but
SBP was higher post-exercise with caffeine consumption. The PEH response was not
observed with either placebo or caffeine (3).
In contrast to the above studies, Anunciaco and colleagues (2) reported caffeine
intake does not interfere with recovery blood pressure. Participants in the study were 10
healthy, physically active, normotensive men. Prior to the exercise sessions, participants
were instructed to avoid alcohol and caffeine consumption as well as any vigorous
activity for at least 72 hours. Each participant was evaluated for both treatments at least
72 hours apart. Resting blood pressure was measured after 10 minutes of seated rest and
followed by ingestion of either caffeine (4 mg/kg) or placebo in identical capsules. Blood
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pressure was measured again for one-hour post-ingestion in 10-minute intervals before
the exercise session. Participants completed 50 minutes of aerobic exercise on a cycle
ergometer at 60% VO2PEAK. The test was followed by 60 minutes of seated rest with BP
assessed every 10 minutes with an automated device. Results from the study found no
significant difference in BP before, during, or after exercise following caffeine
consumption when compared to placebo. Therefore, this study suggests caffeine has no
impact on aerobic PEH (2).
Finally, a few studies have determined the effect of caffeine on PEH as a
secondary outcome measure (10, 63). The first study investigated the acute effect of
caffeine as an ergogenic aid in anaerobic exercise (63). Participants were 19 highly
trained male athletes aged 18-40 years. Prior to the study participants were asked to
abstain from any caffeine for 48 hours and fast for 8-12 hours. Upon arrival, resting
measurements were obtained and participants were given a commercially made shake
with caffeine (5 mg/kg) or without caffeine. Fifteen minutes after participants consumed
the shake, a standardized breakfast was served. An hour after consumption of the shake,
participants began the exercise intervention. The anaerobic exercise session included a
10-minute warm-up, 3 exercise tests with 60 second rest between each, of leg press, chest
press, and the Wingate. Blood pressure was measured post-exercise for an unspecified
amount of time and the result was a significant increase in systolic PEH with caffeine
compared to placebo (63). Conversely, Bunsawat et al (10) evaluated the effect of
caffeine on autonomic recovery following aerobic exercise in 18 young and apparently
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healthy adults. Participants were instructed to refrain from caffeine, alcohol, food, and
strenuous physical activity for at least 12 hours before testing. As a crossover study,
participants were evaluated in both conditions and all tests were completed at the same
time of day (7:00 am - 10:00 am). After 15 minutes of supine rest, baseline measurements
were obtained and then participants ingested either a 400 mg caffeine or placebo capsule.
A VO2MAX treadmill test was administered 45 minutes after. Once the test was finished,
participants rested in the supine position while measurements were performed at 5, 15,
and 30 minutes. The significant finding of this study regarding blood pressure was that
compared to baseline, caffeine significantly increased DBP at all time points while no
difference in SBP was observed (10).
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METHODS
Participants
Men and women between the ages of 18-65 years, with elevated BP (SBP 120129 mmHg and/or DBP: >80 mmHg) or stage 1 hypertension (SBP: 130-139 mmHg
and/or DBP: 80-89 mmHg) were recruited for this study. Interested participants were
initially asked questions regarding caffeine consumption, physical activity habits, resting
blood pressure, and medical history. Participants were considered recreationally
resistance trained (2-3 days/week for ≥ 2 months with prior technique experience with the
assigned lifts) and caffeine-habituated (≥ 200 mg/day). Participants were excluded if they
were pregnant or currently breastfeeding and/or used any medication or supplement with
cardiovascular effects. Additionally, participants were excluded if they were current
smokers or had smoked in the last 6 months. Participants were apparently healthy with no
reported signs or symptoms of cardiovascular disease as indicated by a pre-participation
screening questionnaire. All participants signed an informed consent. This study was
approved by the Stephen F. Austin State University Institutional Review Board.
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Protocol
General Design: For this study, a randomized, double-blind, placebo-controlled,
crossover design was implemented in which the post-exercise blood pressure response
was observed following resistance exercise with and without caffeine supplementation.
Participants were asked to report to the lab on 4 separate occasions over the course of
approximately 8 days. A sample study timeline is provided in Figure 1. Participants were
asked to fast for at least 2 hours prior to any visit as well as refrain from caffeine, alcohol,
and exercise for at least 24-hours. Participants were instructed to maintain a similar diet
in the 24-hours prior to any visit.
Blood Pressure Screening & Anthropometric Measures: Potential participants
who met the inclusion criteria came to the Fitness and Human Performance Lab for
official blood pressure (BP) screening to determine whether or not they satisfied the
elevated or stage 1 hypertensive criteria. After 10 minutes of seated rest in a quiet,
temperature-controlled room, BP was measured with a properly fit automatic
oscillometric cuff (Omron Intellisense, Japan) on the participants left arm. The test-retest
reliability of the cuff was previously determined with a Pearson R of .972 for SBP and
.948 for DBP. Participants were instructed to sit with back supported and feet flat on the
ground with arm rested at heart level. Additionally, participants were asked to remain
quiet and still throughout measurements. Blood pressure was measured every 2 minutes
for a total of 3 measurements. The average of the 3 measurements was used to determine
blood pressure status. These procedures were repeated a second time, at least 24 hours
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later, in order to confirm BP status. Following BP screening, anthropometric values of
eligible participants were recorded: height, weight, and body fat percentage (DEXA).
Maximum Strength Assessment: One-repetition maximum (1-RM) tests were
performed at least 72 hours prior to intervention. A specified 5-10 repetition warm-up
was completed once participants were given instructions on proper form and safety.
Following the warm-up, participants performed a 1RM assessment according to Baechle
and Earle (5) guidelines for barbell bench press, seated 45º leg press, barbell shoulder
press, and cable row. A conservative, near maximal load was estimated in which the
participant was able to complete 2-3 reps. If successful, the participant rested for 2-4
minutes and then attempted a 1RM by increasing the weight by 5-10% for the upper body
lifts and 10-20% for lower body. If unsuccessful, the load was decreased by 2.5-5% for
upper body lifts and 5-10% for lower body. This process was repeated 3-5 times until the
participant was able to properly execute only one complete repetition (5).
Post-Exercise Hypotension Intervention: The two exercise trials in which postexercise blood pressure was measured occurred at least 72-hours apart. In order to
eliminate the morning-associated diurnal variations in BP, all trials were conducted
between the hours of 3:00 and 7:00 pm (31). Upon arrival at the lab, participants were
asked to verbally confirm whether or not they refrained from caffeine, alcohol, and
exercise for at least 24-hours. Then, participants sat in a quiet, temperature-controlled
room for 10 minutes. After seated rest, baseline BP was measured as previously
described and the average of 3 measures was recorded.
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Once baseline BP measurement was complete, participants consumed 12 ounces
of sports drink with either caffeine (3 mg/kg of body weight) dissolved in the beverage or
the same sports drink without caffeine (placebo) in a randomized, double-blinded
fashion. The look and flavor of the beverage was identical for the caffeine and placebo
trials.
Forty five-minutes following beverage consumption, participants completed a
brief warm-up (10 minutes) and then a resistance exercise session that consisted of 4 sets
of 10 repetitions with 90 seconds rest between sets for the following exercises: bench
press and shoulder press at 70% 1RM and 45º leg press and cable row at 75% (3). Heart
rate, rating of perceived exertion, and the number of reps achieved was recorded
following each set during the exercise bouts. Additionally blood pressure was measured
by the same automatic device following the 4th set of each exercise.
Once the resistance exercise session was complete, participants returned to the
seated position and post-exercise blood pressure was measured every 10 minutes for 90
minutes.
Statistical Analysis
A 2-way (condition x time) repeated measures ANOVA was used for statistical
analysis. Using the mean values for each dependent variable, main effects for condition
(caffeine and placebo) and time (pre-beverage, pre-exercise, immediately post-exercise,
and 10, 20, 30, 40, 50, 60, 70, 80 and 90 min post-exercise) were determined, as well as
any condition x time interaction. Significant main effects were followed up with pairwise
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comparisons (least significant differences). Interactions were followed up with dependent
t-tests between conditions at a given time point. All statistical analyses were performed in
SPSS.
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RESULTS
Subject demographic and BP screening data are displayed in Table 1. Maximal
strength (1RM) testing data are displayed in Table 2. Workout data for the two conditions
are presented in Table 3. There we no differences between conditions for workout
volume (reps completed), perceived intensity (RPE), or any of the physiological
measures recorded between sets (HR and BP).
The mean values for SBP from 45-minutes pre-exercise prior to beverage
consumption to 90 minutes post-exercise for each condition are displayed in Figure 2.
There was a main effect for condition (p = 0.017), time (p = 0.017), and a trend towards a
significant condition x time interaction (p = 0.088). The interaction was followed up by
dependent t-tests that revealed significantly greater SBP at 30, 50, 70, and 80 minutes
post-exercise for the caffeine compared to placebo condition. There was also a strong
trend toward significant (p < 0.06) between condition differences at the PRE-EX and 70
minute post-exercise time points. Pairwise comparisons for time revealed significantly
greater SBP pre-exercise, 45 minutes after beverage consumption (PRE-EX) compared to
pre-beverage consumption (PRE-BEV). The average change in SBP from pre-exercise
prior to beverage consumption to 20-90 minutes post-exercise for each condition is
displayed in Figure 3. A dependent t-test revealed a statistically significant difference
between conditions (p < 0.005).
The mean values for DBP from 45-minutes pre-exercise
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prior to beverage consumption to 90-minutes post-exercise for each condition are
displayed in Figure 4. There was a main effect for time (p = 0.034), but no main effect for
condition or condition x time interaction
The mean values for MAP from 45-minutes pre-exercise prior to beverage
consumption to 90-minutes post-exercise for each condition are displayed in Figure 5.
There was no main effect for time (p = 0.106), but a trend towards significance for
condition (p = 0.07), as well as towards a significant condition x time interaction (p =
0.075). The interaction was followed up by dependent t-tests that revealed significantly
greater MAP only at the pre-exercise (PRE-EX) time point, 45 minutes after beverage
consumption for the caffeine compared to placebo condition. There was also a trend
toward significant (p < 0.10) between condition differences at the 20 and 70 minutes
post-exercise time points. The average change in MAP from pre-exercise prior to
beverage consumption to 20-90 minutes post-exercise for each condition is displayed in
Figure 6, although the differences were not significant (p = .237).
The mean values for HR from 45-minutes pre-exercise prior to beverage
consumption to 90-minutes post-exercise for each condition are displayed in Figure
7. There was a main effect for time (p < 0.001), no main effect for condition (p = 0.202),
and a significant condition x time interaction (p = 0.034). The interaction was followed
up by dependent t-tests, but no significant between conditions differences were found at
any particular time point. However, the immediately post-exercise time point (p = 0.051)
appears to be driving the condition x time interaction observed. Pairwise comparisons for
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time revealed significantly greater HR immediately post-exercise (IPE), and at 10, 20,
and 30 minutes post-exercise compared to before exercise prior to beverage consumption
(PRE-BEV), regardless of condition.
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DISCUSSION
The aim of the present study was to investigate the effects of pre-exercise caffeine
supplementation on the post-exercise hypotensive response to a bout of resistance
training in recreationally trained adults with above normal blood pressure. Key findings
of the study include: (a) caffeine (3 mg/kg) significantly increased pre-exercise SBP; (b)
caffeine resulted in significantly greater post-exercise SBP at 30, 50, 60, 70, 80 minutes
compared to placebo; and (c) while resistance exercise at 70-75% 1RM did result in
systolic-PEH (-4 mmHg), the hypotensive response was reversed by caffeine
supplementation (+4 mmHg).
The observed systolic PEH following resistance exercise, as well as the absence
of diastolic PEH, is supported by previous data (13, 17, 22, 30, 32, 56). It is postulated
that diastolic PEH does not occur when there is a decrease in venous return and
baroreflex with a subsequent decrease in CO accompanied by an increase in PVR (54).
Contradictory to the present findings, there are studies that have observed both systolic
and diastolic PEH (8, 38, 54). These differences may be due to differences in
methodology and participant characteristics between studies. For example, it appears that
those with higher baseline BP (8), less training experience (38), and lower
intensity/volume is more effective at eliciting diastolic PEH (54). Nonetheless, the
current exercise prescription was effective at eliciting systolic PEH and the purpose of
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the present study was to investigate whether or not caffeine supplementation would
eliminate this response.
Because of its’ stimulatory effects, caffeine has been postulated to mitigate the
hypotensive response following exercise. While the current resistance exercise
prescription did result in PEH, caffeine supplementation not only eliminated PEH, but
instead caused a hypertensive response. As a more novel area of research, the
corresponding data is limited. To our knowledge, only three studies have investigated the
effect of caffeine on post-resistance exercise BP and the current body of literature has
similar, yet divergent conclusions (3, 58, 63). The caffeine-associated increase in postexercise systolic BP, and change in duration of PEH, was observed in all three studies. As
for DBP, the overarching consensus was that caffeine had no significant effect. On the
contrary, a study did report that regardless of caffeine supplementation, intense resistance
exercise eliminated the PEH response (3), while another reported that, although caffeine
significantly increased SBP, PEH was still present at early time points (58). Both studies,
and the present, prescribed resistance exercise of 70-80% 1RM, yet the caffeine dosage
and other methodology varied.
To start, Souza et al., (58) used a 4 mg/kg caffeine dose and implemented 9-hour
ABPM. The use of ABPM, as opposed to BP measurement within a controlled setting,
adds some external validity, while sacrificing internal validity. The lack of, or unreported,
control for activity during the 9-hour BP measurement window may have influenced the
overall appearance of PEH in the caffeine and placebo condition (58). As such, the
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present study assessed BP in a controlled setting, in the seated position, to expand upon
the baseline understanding of how caffeine may influence the PEH response. The current
methodology did account for external validity through the use of seated recovery vs
supine, as well as allowing subjects to partake in activities such as scrolling their phone,
doing homework, listening to music/podcasts, etc., while remaining seated, between the
BP measures. Souza et al. (58) also used a higher dose than the current study, albeit just a
1 mg/kg difference, the dose still equaled more than the amount of caffeine found in an
average cup of coffee and pre-workout supplement.
Conversely, Astorino et al., (3) suggested PEH was eliminated due to intense
resistance exercise. However, it is difficult, and possibly erroneous, to completely
attribute the lack of PEH to 1RM intensity as subjects performed maximal reps to failure
for 4 sets (3). It is plausible that the increased volume masked the hypotensive response
as other resistance exercise PEH studies have observed PEH at a similar intensity (8, 17,
22, 30, 54). The present study prescribed a more commonly implemented exercise
prescription within the general population (4 sets of 10 reps at 70-75% 1RM) and still
observed PEH in the placebo condition. Besides the increase volume in the Astorino
study, the prescribed caffeine dose was double that of the present study (6 mg/kg) and is
significantly greater than that of a cup of coffee or pre-workout supplement (3). Again,
we observed similar deleterious effects of caffeine on PEH with not only half the dose,
but a more realistic dose of pre-workout caffeine. As such, the results of the present study
support the use of intense resistance exercise as an alternative anti-hypertensive
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therapeutic approach as well as highlights the unintended consequences of pre-workout
caffeine consumption.
A possible explanation behind the caffeine-induced pressor effect shown with
SBP is likely the antagonization of adenosine receptors (18, 33). As a result, plasma
levels of adenosine accumulate and an increase in sympathetic tone, circulating
catecholamines, and peripheral vascular resistance (PVR) occurs. Thus, the vasodilatory
effect normally observed post-exercise is reduced or eliminated (33). The decrease in
sympathetic tone and PVR following exercise are strongly believed to be defining
characteristics of PEH (23, 27). Based on results of the present study, we speculated that
caffeine may offset the decrease in both factors, and in turn, cause vasoconstriction that
manifests as the elimination of PEH.
Given the current findings, the present study is not without limitation. One
limitation was the small sample size (n =5). Despite the limited sample size, the large
effect size in the systolic PEH response still allowed for the study to be adequately
powered (> .80) for this particular dependent variable. A larger sample may help clarify
the effect of caffeine on DBP and MAP post-exercise. Participants were largely collegeaged, Caucasians with slightly above normal BP. As such, caution should be used when
extrapolating the results of this study to other populations, as subject characteristics (race,
age, BP status) can greatly influence PEH. Another limitation was the absence of
hemodynamic variable measurement (CO, SV, PVR, HRV) that could have given more
insight into the observed PEH response and specific mechanisms responsible. Lastly,
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despite best efforts in matching the taste of both beverages, all participants complained of
a bitter taste in the caffeine condition. This introduces a potential bias and influence of
PEH results, but highly unlikely that participants were able to significantly manipulate
the physiological BP response.
Future research should include more subject populations, including medicated and
nonmedicated hypertensives, as they are likely to benefit the most from resistance
exercise and the benefits of the PEH response. Even a small 2 mmHg decrease in SBP is
associated with a 14% and 9% reduced risk of stroke and coronary artery disease,
respectively (62). More attention should also be placed on the manipulation of various
factors of the exercise prescription (intensity, total volume, rest, etc). In regard to the
specific caffeine-PEH relationship, future research should include supplementation with
popular pre-workout blends that include caffeine, as other supplements in these blends
may also impact blood pressure. Lastly, future research should investigate the effect of
caffeine on hemodynamic variables of PEH to gain a deeper, more robust understanding
of their relationship.
Once more, the present study supports the use of resistance exercise in the early
management of high blood pressure development and it underscores the potential
cardiovascular health risks of caffeine prior to resistance exercise. This is particularly
true if blood pressure is a concern, which is the case for a large majority of the population
(64). Almost 50% of U.S. adults have HTN and another 30% are considered to have
elevated BP (64). Therefore, nearly 80% of Americans should be mindful of blood
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pressure and perform exercise for the health-related benefits. The sports supplement
industry, particularly energy drinks and MIPS, has grown exponentially, and continues to
market these products to the general population as a necessity (29, 53). However, these
individuals do not require the ergogenic benefit of caffeine and this study suggests they
should avoid pre-workout caffeine supplementation as it negates the critical antihypertensive benefit of PEH.
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Table 1. Demographic, body composition, and resting blood pressure values obtained
from initial fitness screening of individuals with above normal blood pressure.
Variables

Men (n = 3)

Women (n = 2)

Total (n = 5)

Age (years)

23 ± 2

25 ± 5

23 ± 3

Weight (kg)

88 ± 6

70 ± 25

80 ± 16

Height (in)

69 ± 1

64 ± 3

67 ± 3

Body Fat (%)

31 ± 14

34 ± 12

32 ± 12

Systolic Blood
Pressure (mmHg)

127 ± 6

125 ± 8

126 ± 6

71 ± 10

82 ± 2

76 ± 9

90 ± 6

97 ± 3

92 ± 6

74 ± 9

74 ± 9

74 ± 8

Diastolic Blood
Pressure (mmHg)
Mean Arterial
Pressure
(mmHg)
Heart Rate (bpm)

All values represent mean ± SD. Blood pressure and heart rate values averaged across
two screening visits.
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Table 2. Maximal strength (1-repetition maximum) values from initial fitness
assessment of individuals with above normal blood pessure.
Variables

Men (n = 3)

Women (n = 2)

Total (n = 5)

333 ± 115

185 ± 59

274 ± 119

Barbell Shoulder
Press

53 ± 22

29 ± 5

43 ± 21

Cable Row

77 ± 24

45 ± 13

64 ± 25

Bench Press

87 ± 43

36 ± 10

67 ± 41

45º Leg Press

All values represent mean ± SD. All units in kg.

Table 3. Comparison of resistance exercise session data (4 exercises x 4 sets x 10 reps)
for placebo and caffeine conditions in individuals with above normal blood pressure (n
= 5).
Variables

Placebo

Caffeine

p - value

Total Reps

158 ± 5

159 ± 3

0.374

Rating of
Perceived Exertion

13 ± 1

13 ± 2

0.737

Heart Rate (bpm)

143 ± 19

149 ± 25

0.150

Systolic Blood
Pressure (mmHg)

123 ± 3

125 ± 9

0.567

Diastolic Blood
65 ± 9
67 ± 8
0.589
Pressure (mmHg)
All values represent mean ± SD. p-values from dependent t-test comparing conditions.
RPE and HR data averaged from the end of each set. BP data averaged from end of
each exercise. Exercises included leg press, bench press, cable row, shoulder press.
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Figure 1. Sample timeline for blood pressure screening, fitness assessment, and
resistance exercise post-exercise hypotension (PEH) trials for randomized, double-blind
caffeine and placebo conditions.
Figure 2. Systolic blood pressure (mmHg) pre-exercise before beverage consumption
(PRE-BEV), 45 minutes post-beverage consumption prior to exercise (PRE-EX),
immediately post-exercise (IPE), and at 10, 20, 30, 40, 50, 60, 70, 80, 90 minutes postexercise for caffeine and placebo conditions. *Significant difference (p < 0.05) between
conditions at same time point. †Time point significantly different (p < 0.05) than PREBEV time point, regardless of condition.
Figure 3. Change in systolic blood pressure (mmHg) from pre-exercise before beverage
consumption to post-exercise (20-90 minutes post) for caffeine and placebo conditions.
*Significant difference (p < 0.05) between conditions.
Figure 4. Diastolic blood pressure (mmHg) pre-exercise before beverage consumption
(PRE-BEV), 45 minutes post-beverage consumption prior to exercise (PRE-EX),
immediately post-exercise (IPE), and at 10, 20, 30, 40, 50, 60, 70, 80, 90 minutes postexercise for caffeine and placebo conditions.
Figure 5. Mean arterial pressure (mmHg) pre-exercise before beverage consumption
(PRE-BEV), 45 minutes post-beverage consumption prior to exercise (PRE-EX),
immediately post-exercise (IPE), and at 10, 20, 30, 40, 50, 60, 70, 80, 90 minutes postexercise for caffeine and placebo conditions. *Significant difference (p < 0.05) between
conditions at same time point.
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Figure 6. Change in mean arterial pressure (mmHg) from pre-exercise before beverage
consumption to post-exercise (20-90 minutes post) for caffeine and placebo conditions.
Figure 7. Heart rate (bpm) pre-exercise before beverage consumption (PRE-BEV), 45
minutes post-beverage consumption prior to exercise (PRE-EX), immediately postexercise (IPE), and at 10, 20, 30, 40, 50, 60, 70, 80, 90 minutes post-exercise for caffeine
and placebo conditions. †Time point significantly different (p < 0.05) than PRE-BEV
time point, regardless of condition.
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